about
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandardSystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationTests for detecting strabismus in children age 1 to 6 years in the communitySystemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationExtent of non-publication in cohorts of studies approved by research ethics committees or included in trial registriesGonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysisTreatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-AnalysisAuthors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic reviewIn vivo biometry in the mouse eye with low coherence interferometry.Effectiveness of screening preschool children for amblyopia: a systematic review.Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical researchIntravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review.A protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analyses.Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meetingProtocol for a systematic review on the extent of non-publication of research studies and associated study characteristicsEfficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol.Diagnostic accuracy of vision screening tests for the detection of amblyopia and its risk factors: a systematic review.Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.Effectiveness of early in comparison to late(r) treatment in children with amblyopia or its risk factors: a systematic review.Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review.A paraxial schematic eye model for the growing C57BL/6 mouse.Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.Contrast sensitivity of wildtype mice wearing diffusers or spectacle lenses, and the effect of atropine.Tests for detecting strabismus in children aged 1 to 6 years in the community.Prophylactic antibiotics before cord clamping in cesarean delivery: a systematic review.Randomisierte kontrollierte und kontrollierte klinische Studien in deutschsprachigen, ophthalmologischen FachzeitschriftenEfficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis: A Network Meta-analysisMethoden des Evidence MappingsManaging Neovascular Age-Related Macular DegenerationA systematic review on the effect of bevacizumab in exudative age-related macular degenerationGrating Acuity at Different Luminances in Wild-Type Mice and in Mice Lacking Rod or Cone FunctionFull publication of results initially presented in abstractsThe prevalence of hearing loss and use of hearing aids among adults in Germany: a systematic review[Risk of bias in controlled clinical trials]Prevalence of hearing loss and use of hearing aids among children and adolescents in Germany: a systematic reviewEvaluating the Diagnostic Accuracy of the Head-Impulse Test: A Scoping ReviewNaturopathic Treatment and Complementary Medicine in Surgical PracticeMilk A1 β-casein and health-related outcomes in humans: a systematic review[Risk of bias in controlled clinical trials]
P50
Q21090878-7F9F35F8-B22E-4B3E-ACAF-C99BBAC8A7BEQ24193614-763980D8-901A-4476-8AB1-A4938F23E6BCQ24194955-740145B5-DFB2-4D3A-9276-9940BA0A8AD0Q24195003-C968C64A-8CFE-4559-9DA4-E4166FA4380BQ24288672-6268A3C5-8F08-46D9-A6B1-DF99AE129192Q26777150-2E8AC6EE-1E68-4F34-AC0B-CFAE80190C3AQ26787156-02DAB301-3885-4373-86A9-D886CEC398C8Q26996522-16FE8EAD-4211-4E6A-8807-C1DDE2EBA62CQ33206623-7ECF64B0-85EA-4C89-80E1-CE45539ADD93Q33483070-9DDB8A9B-419C-41F4-9B20-90407E9827D1Q33602408-DDA0CA34-EB90-49E9-ACB2-E0A9BAE198A6Q33726705-D7FE62CE-5914-4E33-B096-4B5A263AA1E5Q34698688-877DAE66-0FA1-436C-8301-C54F1F8462A9Q35036495-A2FD5656-DD4F-4448-82DA-F384CF4054AEQ35604866-F801E734-336E-4122-AD7B-5776AE6B298BQ36624659-79AD228D-85DD-4671-8AC3-E37CAB2A5569Q36865740-63641157-CB37-4F99-9FB8-7C19B78136E9Q37577715-B4B51183-7B64-4F7D-B3D5-3D5E05063C9FQ37612106-35A07606-BA53-43C3-B0F3-92D5C0307FC5Q37680991-ED4A76C7-A534-4AF6-9C86-151978877AD9Q37731232-7B553D42-5820-4530-82E2-88A64B1EBDB4Q44897677-13A0B5CB-8B64-4180-BE28-9423CBC552D9Q46301140-8D39DE0E-8538-427D-8637-23DBB2652D40Q46580220-18B580FD-76D1-4B7A-9BD7-274D2DD94AD1Q47653823-A7119848-35E0-4B0D-A616-4F1D94161B65Q48160933-C8B95063-1642-4135-BCCF-FD805D2244F1Q56889657-DED55124-2C3D-4855-9C4D-8A6A28F61085Q57039048-E1FAFC7E-DF18-4541-AB92-1C32453349BEQ57307410-1FEC5897-80D9-427C-B3D8-087C98CD9CE3Q57776102-4EF8E75B-7CC2-47C7-8416-95933EA994ECQ57776187-E3B52E5A-BBD0-4000-91BE-2EA4F396100FQ57776199-FC43F4B0-D59A-4D46-B64A-2FBF7F0B4AB3Q63367934-9E7F237E-17F5-4321-AD02-3530F3D60135Q64273530-D2041CB9-B686-46ED-8FEE-20DD3D2CE13DQ89901496-4D20E7D1-A56D-45BE-8091-1F32E71EC6D5Q90165992-4DDE6EA2-6D8D-43B6-82E8-4E04CBF59F27Q90300296-E7B46E7E-D91D-4108-9BC1-77666C8F84B2Q91207346-E6D8C308-ACCC-474B-8BD6-778439EC1272Q91355631-34DACDBF-C6B8-4977-82A5-94230B29BB92Q92189683-CE2754C8-1F8A-4FF9-A98D-150933FA29D3
P50
description
hulumtuese
@sq
oogarts
@nl
researcher
@en
ricercatrice
@it
taighdeoir
@ga
հետազոտող
@hy
name
Christine Schmucker
@ast
Christine Schmucker
@en
Christine Schmucker
@es
Christine Schmucker
@fr
Christine Schmucker
@nl
Christine Schmucker
@sl
type
label
Christine Schmucker
@ast
Christine Schmucker
@en
Christine Schmucker
@es
Christine Schmucker
@fr
Christine Schmucker
@nl
Christine Schmucker
@sl
prefLabel
Christine Schmucker
@ast
Christine Schmucker
@en
Christine Schmucker
@es
Christine Schmucker
@fr
Christine Schmucker
@nl
Christine Schmucker
@sl
P214
P227
P21
P213
0000 0000 1729 750X
P214
P227
P31
P496
0000-0002-1188-3158
P569
1974-01-01T00:00:00Z
P735
P7859
viaf-67571160